Tumor-associated macrophages (TAMs) can have a tumorinhibiting M1 phenotype or a tumor-promoting M2 phenotype, but they can also have mixed phenotypes, undergo phenotype switching upon stimulation, and develop into subpopulations that show differences in antigen expression. [3] [4] [5] [6] [7] The presence of M2 macrophages has been associated with worse clinical outcome in several malignancies 8, 9 and is thought to affect disease outcome by stimulating angiogenesis, metastasis, immune suppression and possibly by reducing the effectiveness of certain treatments. 3, 4, [10] [11] [12] Previous studies of PCa tissue reported that high numbers of TAMs are associated with poor clinical outcome; however, contradicting results have been reported. 7, [13] [14] [15] [16] [17] [18] [19] A major limitation of most of these studies is the use of CD68 to identify macrophages, since this marker cannot distinguish between M1 and M2 macrophages. 7, [13] [14] [15] [16] [17] The scavenger receptor CD163 is associated with an anti-inflammatory macrophage phenotype and is currently the most specific marker for identifying M2 macrophages. 20 Recent studies found that high numbers of CD163-positive M2 macrophages in prostate tumors were associated with poor outcome. 18, 19 Regulatory T cells (T regs ) are another type of immune cell that contributes to tumor development by suppressing anti-tumor immunity. 21 Growing evidence supports the hypothesis that an elevated number of T regs in PCa patients confers poor prognosis and decreases survival rates. [22] [23] [24] Recently, when using the same PCa cohort we found that the number of T regs was associated with a greater likelihood of death from PCa. 25 Studies show a correlation between increased numbers of T regs and macrophages in several types of cancer [26] [27] [28] [29] ; however, to the best of our knowledge, this has not been investigated in prostate tumor progression. This study evaluated the prognostic value of M2 macrophages in a large PCa cohort with long-term follow-up. We also investigated the correlation and interaction of M2 macrophages and T regs .
| MATERIALS AND METHODS

| Tissue samples
This study was nested within a cohort of men with localized PCa patients who were diagnosed with incidental PCa through transurethral resection of the prostate (TUR-P) or adenoma enucleation, that is, category T1a-b tumors, were identified. All patients were followed expectantly (watchful waiting) according to the standard treatment protocols in use at that time. Record linkages to the Swedish Death Register and Migration Register were used to follow the study cohort for cancer-specific and all-cause mortality until 1 March 2006.
The cohort was described in detail previously. 25, 30 Within this cohort, we utilized a nested study design that we described previously. 25 The study included men who either died from or developed metastatic PCa during follow-up (lethal PCa cases, N = 261) and men who survived at least 10 years following their diagnosis without disease progression (indolent PCa controls, N = 474).
At the time of our study, there was sufficient high-quality tissue available from 225 cases and 367 controls. The study was approved by the Ethical Review Boards in Örebro and Linköping, Sweden.
| Immunohistochemistry
Tissue microarrays (TMAs) were created previously for this cohort using tissue cores with a diameter of 0.6 mm from each TUR-P specimen. The TMA blocks included three tissue cores from each patient in order to address potential tumor heterogeneity. TMA sections of 4 μm were used for immunohistochemistry (IHC). The TMA sections were dried at 60°C, deparaffinized, rehydrated, and HIER- Tucson, AZ) as described previously. 31 The tissue was counterstained using hematoxylin and mounted using Vectashield mounting media 
| Statistical analysis
The mean number of macrophages in three tissue cores from each patient was used for statistical analyses. 3 | RESULTS
| Clinical characteristics and PCa outcome
The number of M2 macrophages were counted in prostate tissue samples from men who either died from or developed metastatic PCa Table 1 .
| IHC analysis of the M2 macrophage marker CD163
The IHC analysis of the M2 macrophage marker CD163 showed that 
| CD163-positive macrophages and clinicopathological features
There was a significant correlation between the number of M2 macrophages and T regs (P < 0.001), even though no interaction between the two cell types was found (P = 0.290). There was significantly greater infiltration of M2 macrophages in lethal cases than in indolent controls (P < 0.001). Our data also showed a strong association between the number of M2 macrophages and GS (P < 0.001), with higher numbers of CD163-positive macrophages in more aggressive tumors (GS 8-10). We found no association between tumor stage and the number of M2 macrophages (Table 2 ).
| M2 macrophages and the risk of lethal PCa
The odds of dying of PCa were estimated in patients categorized as having high numbers (>25 macrophages/core) or low numbers (≤25 macrophages/core). In the unadjusted analyses, we observed that men with high numbers of M2 macrophages had a two-fold increase in the odds of dying of PCa (OR: 2.05; 95%CI: 1.46-2.88) compared to men with low numbers of M2 macrophages ( Table 3 ). The odds of dying from the disease were significantly increased for men with a high number of M2 macrophages even after adjusting for age at diagnosis, We also found a significant correlation between the number of CD163-positive M2 macrophages and T regs (P < 0.001).
TAMs in PCa are associated with poor prognosis, but this has mainly been investigated using the CD68 antigen, 7,13-17 which is expressed on both M1 and M2 macrophages. 4, 6, 18 However, M2 macrophages can be distinguished from M1 macrophages using antibodies that recognize CD163. This is of great importance in studies that investigate the impact of macrophages in carcinogenesis, since M1 macrophages and M2 macrophages play opposing roles in the tumor environment. 4, 6 In the present study, we examined the infiltration of CD163-positive M2 macrophages in a large and clinically well-defined PCa cohort, and our results demonstrated that men with high numbers of M2 macrophages had a nearly two-fold increased odds of dying of PCa. This is in line with the results recently presented in a meta-analysis showing that a higher density of CD68-positive macrophages was associated with poorer overall survival. 5 To our knowledge, only two previous studies have investigated CD163-positive macrophages in PCa tissue. The first study, by in estimating prognosis compared to using each cell type separately.
One possible explanation for the correlation between M2 macrophages and T regs found in the present study is that M2 macrophages can produce immunosuppressive cytokines and chemokines that are involved in recruiting lymphocytes and stimulating them to develop into T regs . 32, 33 In addition, T regs produce high levels of IL-10, IL32, and TGFβ that further suppress the anti-tumor inflammatory response and stimulate M2 macrophages to increase their production of cytokines and chemokines that enable additional recruitment of T regs. 34 Recently, using the same cohort as in the current study we found high iNOS expression in prostate tumor cells from men with aggressive PCa. 35 One additional explanation for the high number of M2 macrophages and T regs in tissue from patients with lethal PCa could be that a high level of iNOS consumes L-arginine that could contribute to the activation and/or recruitment of myeloid-derived suppressor cells, T regs , and macrophages. 36, 37 Our data support the hypothesis that M2 macrophages and T regs form a niche in the tumor environment that promotes tumor progression. Based on this, therapeutic strategies may benefit from targeting both M2 macrophages and T regs for an efficient treatment of PCa patients.
Our results provide some insights into the role of M2 macrophages and T regs in PCa development. One strength of the study is the long follow-up of the patients, which allowed us to track a substantial number of PCa deaths. A weakness of our study is its use of TMAs, (1977-1982, 1983-1986, 1987-1991, 1992-1998 
